162 related articles for article (PubMed ID: 27044771)
21. Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.
Marengo A; Bitetto D; D'Avolio A; Ciancio A; Fabris C; Marietti M; Toniutto P; Di Perri G; Rizzetto M; Marzano A
Antivir Ther; 2013; 18(1):87-94. PubMed ID: 22872649
[TBL] [Abstract][Full Text] [Related]
22. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy.
Chen CH; Hu TH; Hung CH; Wang JH; Lu SN; Lee CM
J Viral Hepat; 2014 Aug; 21(8):e55-64. PubMed ID: 24766327
[TBL] [Abstract][Full Text] [Related]
23. [Entecavir therapy for patients with hepatitis B virus-related decompensated cirrhosis].
Kim IS; Mun JI; Koo JH; Kang CJ; Bak JK; Cheong JY; Cho SW
Korean J Gastroenterol; 2012 Mar; 59(3):224-31. PubMed ID: 22460571
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
Doğan ÜB; Kara B; Gümürdülü Y; Soylu A; Akin MS
Turk J Gastroenterol; 2012 Jun; 23(3):247-52. PubMed ID: 22798114
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of entecavir treatment in hepatitis B virus-related decompensated cirrhosis].
Kim YS
Korean J Gastroenterol; 2012 Mar; 59(3):203-4. PubMed ID: 22563614
[No Abstract] [Full Text] [Related]
26. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.
Wong GL; Chan HL; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Lai JW; Lo AO; Chan HY; Wong VW
Hepatology; 2013 Nov; 58(5):1537-47. PubMed ID: 23389810
[TBL] [Abstract][Full Text] [Related]
27. Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection.
Lee HW; Park JY; Kim SG; Tak WY; Yim HJ; Jang BK; Kim MY; Kim BI; Lee JW; Yoon KT; Cheong JY; Kwon SY; Kim TY; Bae SH; Seo YS; Kwon JH; Kim DJ; Kim JK; Jeong SW; Myoung S; Ahn SH; Han KH;
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2811-2813.e1. PubMed ID: 30731195
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
[TBL] [Abstract][Full Text] [Related]
29. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis.
Cheng DY; Zhao ZM; Wan G; Zheng HW; Huang JQ; Liu CH; Xing HC
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):479-484. PubMed ID: 35346577
[TBL] [Abstract][Full Text] [Related]
30. Entecavir in decompensated HBV cirrhosis: the future is looking brighter.
Fontana RJ
J Hepatol; 2010 Feb; 52(2):147-9. PubMed ID: 20006400
[No Abstract] [Full Text] [Related]
31. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
32. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
Lian JS; Zeng LY; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
World J Gastroenterol; 2013 Oct; 19(37):6278-83. PubMed ID: 24115827
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.
Song JC; Min BY; Kim JW; Kim JY; Kim YM; Shin CM; Lee SH; Hwang JH; Jeong SH; Kim N; Lee DH
Korean J Hepatol; 2011 Dec; 17(4):268-73. PubMed ID: 22310791
[TBL] [Abstract][Full Text] [Related]
34. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.
Xu Y; Zhang YG; Wang X; Qi WQ; Qin SY; Liu ZH; Jiao J; Wang JB
World J Gastroenterol; 2015 Jul; 21(25):7869-76. PubMed ID: 26167087
[TBL] [Abstract][Full Text] [Related]
35. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment.
Seto WK; Lam YF; Fung J; Wong DK; Huang FY; Hung IF; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2014 May; 29(5):1028-34. PubMed ID: 24325451
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
Pan HY; Pan HY; Song WY; Zheng W; Tong YX; Yang DH; Dai YN; Chen MJ; Wang MS; Huang YC; Zhang JJ; Huang HJ
J Viral Hepat; 2017 Nov; 24 Suppl 1():29-35. PubMed ID: 29082652
[TBL] [Abstract][Full Text] [Related]
37. Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.
Keating GM
Drugs; 2011 Dec; 71(18):2511-29. PubMed ID: 22141390
[TBL] [Abstract][Full Text] [Related]
38. Liver Fibrosis Reversion After Suppression of Hepatitis B Virus.
Rockey DC
Clin Liver Dis; 2016 Nov; 20(4):667-679. PubMed ID: 27742006
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice.
Ridruejo E; Marciano S; Galdame O; Reggiardo MV; Muñoz AE; Adrover R; Cocozzella D; Fernandez N; Estepo C; Mendizabal M; Romero GA; Levi D; Schroder T; Paz S; Fainboim H; Mandó OG; Gadano AC; Silva MO
Ann Hepatol; 2014; 13(3):327-36. PubMed ID: 24756007
[TBL] [Abstract][Full Text] [Related]
40. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
